Back

Have we reached the bottom line in mortality after Acute Myocardial Infarction? Changes over 20 years in patient characteristics, management, and 6-month outcomes in the FAST-MI programme: 1995-2015

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late-Breaking Science in PCI 2 Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

ESC TV

About the speaker

Photo
Professor Nicolas Danchin

Saint Joseph Hospital, Paris (France)

5 More presentations in this session

Presentation thumbnail
The Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction in patients on modern antiplatelet therapy in SWEDEHEART
Professor D. Erlinge (Lund, SE)
Slides Video
Presentation thumbnail
Efficacy and Safety of a Pharmaco-Invasive Strategy versus Primary Angioplasty in ST-Elevation Myocardial Infarction: The EARLY-MYO Trial
Professor B. HE (Shanghai, CN)
Slides Video
Presentation thumbnail
Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes - TROPICAL-ACS - Trial
Professor D. Sibbing (Munich, DE)
Slides Video
Presentation thumbnail
RE-DUAL PCI : Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation
Professor C. Cannon (Boston, US)
Slides Video
Presentation thumbnail
Improvement in FFR predicts 2 years outcome after PCI. A FAME 2 Sub-Analysis.
Doctor S. Fournier (Lausanne, CH)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science in PCI 2

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources